Subependymal giant cell astrocytoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
Sujit Routray (talk | contribs)
Created page with "__NOTOC__ {{Subependymal giant cell astrocytoma}} {{CMG}}{{AE}}{{SR}} ==Reference== {{reflist|2}} Category:Disease Category:Types of cancer Category:Rare disease..."
 
Sujit Routray (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Subependymal giant cell astrocytoma}}
{{Subependymal giant cell astrocytoma}}
{{CMG}}{{AE}}{{SR}}
==Overview==
==Pathophysiology==
===Genetic===
*Development of subependymal giant cell astrocytoma is the result of multiple genetic mutations.
*Genes involved in the pathogenesis of subependymal giant cell astrocytoma include:
===Associated Conditions===
Subependymal giant cell astrocytoma may be associated with [[tuberous sclerosis]].<ref name=AssociationPA1>Associations of pilocytic astrocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pilocytic-astrocytoma. Accessed on October 26, 2015</ref>
===Gross Pathology===
*On gross pathology, subependymal giant cell astrocytoma is characterized by:
*Common intracranial sites associated with subependymal giant cell astrocytoma include:
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px"
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Anatomical Location'''}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Summary'''}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
*[[Cerebellum]]
*[[Third ventricle]]
*[[Optic nerve]]
*[[Optic chiasm]]
*[[Hypothalamus]]
*[[Thalamus]]
*[[Basal ganglia]]
*[[Brain stem]]
*[[Fourth ventricle]]
*[[Spinal cord]]
*[[Cerebral hemisphere]]s
*[[Supratentorial|Supratentorial NOS]]
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
[[File:Location of pilocytic astrocytoma.PNG|thumb|none|700px|<sub>Neuroanatomical distribution of aneuploid pilocytic astrocytoma tumors favors non-cerebellar areas.<ref name=locPA1>{{cite journal|title=Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age|journal=Oncotarget|year=2015|issn=1949-2553|doi=10.18632/oncotarget.5571}}</ref></sub>]]
|}


{{CMG}}{{AE}}{{SR}}
 
===Microscopic pathology===
On microscopic histopathological analysis, subependymal giant cell astrocytoma is characterized by:
 
 
According to the ''WHO classification of tumors of the central nervous system'', subependymal giant cell astrocytoma is classified into a WHO grade I tumor.
 
 
 
===Immunohistochemistry===
Subependymal giant cell astrocytoma is demonstrated by positivity to [[tumor marker]]s such as:


==Reference==
==Reference==
{{reflist|2}}
{{reflist|2}}



Revision as of 21:07, 2 November 2015

Subependymal giant cell astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subependymal Giant Cell Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subependymal giant cell astrocytoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subependymal giant cell astrocytoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subependymal giant cell astrocytoma pathophysiology

CDC on Subependymal giant cell astrocytoma pathophysiology

Subependymal giant cell astrocytoma pathophysiology in the news

Blogs on Subependymal giant cell astrocytoma pathophysiology

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Subependymal giant cell astrocytoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Pathophysiology

Genetic

  • Development of subependymal giant cell astrocytoma is the result of multiple genetic mutations.
  • Genes involved in the pathogenesis of subependymal giant cell astrocytoma include:


Associated Conditions

Subependymal giant cell astrocytoma may be associated with tuberous sclerosis.[1]


Gross Pathology

  • On gross pathology, subependymal giant cell astrocytoma is characterized by:
  • Common intracranial sites associated with subependymal giant cell astrocytoma include:
Anatomical Location Summary
Neuroanatomical distribution of aneuploid pilocytic astrocytoma tumors favors non-cerebellar areas.[2]


Microscopic pathology

On microscopic histopathological analysis, subependymal giant cell astrocytoma is characterized by:


According to the WHO classification of tumors of the central nervous system, subependymal giant cell astrocytoma is classified into a WHO grade I tumor.


Immunohistochemistry

Subependymal giant cell astrocytoma is demonstrated by positivity to tumor markers such as:

Reference

  1. Associations of pilocytic astrocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pilocytic-astrocytoma. Accessed on October 26, 2015
  2. "Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age". Oncotarget. 2015. doi:10.18632/oncotarget.5571. ISSN 1949-2553.


Template:WikiDoc Sources